The Nutrition, Obesity and Atherosclerosis Training Program at the University of Washington is a successful Training Program, now in its 35th year of funding. The overall goal of the program continues to be to provide a highly qualified group of postdoctoral MD clinicians and PhD scientists with the research skills they need to become fully independent biomedical investigators in the areas of nutrition, obesity and atherosclerosis. The training program utilizes 26 investigators at the University of Washington who are performing both basic and clinical research in these areas as preceptors. Use is also made of a number of basic and clinical scientists with whom the core faculty collaborates to broaden research opportunities and resources available to trainees in the program. Trainees entering the program previously have obtained either an MD or PhD degree and MD candidates usually have completed residency training. Some have had some prior research experience. PhD candidates have demonstrated ability in a basic science discipline and have demonstrated capability for research related to the focus of this program. Selection of the 4 candidates supported by this training grant is made by an Executive Committee from a large pool of qualified applicants who continue to apply for research training in metabolism, endocrinology and nutrition at the University of Washington. This program provides trainees with research experience in both basic and clinical science necessary in preparation for independent research careers. Appointments to the Training Program are for at least 2 years, with an optional 3rd year available. The program also includes opportunities for trainees to interact through program-specific meetings, and to present their research to peers, preceptors, and invited scientists from other academic institutions. A series of didactic lectures and seminars related to the topics of lipids, obesity, nutrition and atherosclerosis, as well as in scientific methods and biomedical ethics, complement the research training. Rigorous evaluation of trainees and preceptors is performed bi-annually and is overseen by the Executive Committee and an External Advisory Committee. The Nutrition, Obesity and Atherosclerosis Training Program has been highly successful in training productive scientists, including minority scientists, in these areas during the current funding period, and will provide an even stronger training environment due to several changes in overview, coherence, and training opportunities during the next funding period.
Nutrition and obesity are the major contributors to the cardiovascular disease epidemic in the United States and worldwide. A major reason for the increase in cardiovascular disease is the rapidly increasing prevalence of obesity in both adults and children, many of whom will develop cardiovascular disease, and so the burden on our society is tremendous. The Nutrition, Obesity and Atherosclerosis Training Program trains new generations of postdoctoral MD clinicians and PhD scientists to tackle these problems.
|Runchey, Shauna S; Boyko, Edward J; Ioannou, George N et al. (2014) Relationship between serum circulating insulin-like growth factor-1 and liver fat in the United States. J Gastroenterol Hepatol 29:589-96|
|Averill, Michelle M; Kim, Eung Ju; Goodspeed, Leela et al. (2014) The apolipoprotein-AI mimetic peptide L4F at a modest dose does not attenuate weight gain, inflammation, or atherosclerosis in LDLR-null mice. PLoS One 9:e109252|
|Cooper, Lori A; Page, Stephanie T (2014) Androgens and prostate disease. Asian J Androl 16:248-55|
|Runchey, Shauna S; Valsta, Liisa M; Schwarz, Yvonne et al. (2013) Effect of low- and high-glycemic load on circulating incretins in a randomized clinical trial. Metabolism 62:188-95|
|Montes, Vince N; Turner, Michael S; Subramanian, Savitha et al. (2013) T cell activation inhibitors reduce CD8+ T cell and pro-inflammatory macrophage accumulation in adipose tissue of obese mice. PLoS One 8:e67709|
|Chira, Ebele C; McMillen, Timothy S; Wang, Shari et al. (2007) Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, reduces atherosclerosis in female low density lipoprotein receptor deficient mice. Atherosclerosis 195:100-9|
|Utzschneider, Kristina M; Carr, Darcy B; Barsness, Suzanne M et al. (2004) Diet-induced weight loss is associated with an improvement in beta-cell function in older men. J Clin Endocrinol Metab 89:2704-10|
|Steinberg, F M; Chait, A (1998) Antioxidant vitamin supplementation and lipid peroxidation in smokers. Am J Clin Nutr 68:319-27|
|Steinberg, F M; Tsai, E C; Brunzell, J D et al. (1996) ApoE enhances lipid uptake by macrophages in lipoprotein lipase deficiency during pregnancy. J Lipid Res 37:972-84|
|Friday, K E; Drinkwater, B L; Bruemmer, B et al. (1993) Elevated plasma low-density lipoprotein and high-density lipoprotein cholesterol levels in amenorrheic athletes: effects of endogenous hormone status and nutrient intake. J Clin Endocrinol Metab 77:1605-9|
Showing the most recent 10 out of 14 publications